학술논문
Mezigdomide is effective alone and in combination with menin inhibition in preclinical models of KMT2A-r and NPM1c AML
Document Type
Article
Author
Bourgeois, W.; Cutler, J.A.; Wenge, D.V.; Perner, F.; Martucci, C.; Henrich, J.A.; Klega, K.; Boileau, M.; Wen, Y.; Hatton, C.; Apazidis, A.A.; Olsen, S.N.; Pikman, Y.; Pollard, J.A.; Perry, J.A.; Crompton, B.D.; Armstrong, S.A.; Aubrey, B.J.; Sperling, A.S.; Ebert, B.L.; Nowak, R.P.; Donovan, K.A.; Kirmani, N.; Fischer, E.S.; McGeehan, G.M.
Source
In: Blood . (Blood, 11 April 2024, 143(15):1513-1527)
Subject
Language
English
ISSN
15280020
00064971
00064971